In Situ Reconstruction in Native and Prosthetic Aortic Infections Using Cryopreserved Arterial Allografts  by Touma, J. et al.
Selected Abstracts from the September Issue of the
European Journal of Vascular and Endovascular Surgery
A.RossNaylor,MBChB,MD, FRCS, Editor-in-Chief, and PhilippeH.Kolh,MD, PhD, Senior EditorActivation of the Proapoptotic Unfolded Protein Response in Plaques
of the Human Carotid Artery
Dorweiler B., Grechowa I., Wallrath A., Vahl C.F., Horke S. Eur J Vasc
Endovasc Surg 2014;48:250-9.
Objective: To analyze expression of keystone markers of apoptosis
and the proapoptotic signaling pathway “unfolded protein response”
(UPR) in rupture-prone plaques of the human carotid artery.
Methods: Plaque specimens were obtained during endarterectomy
for high-grade carotid stenosis, and were formalin-ﬁxed. Ten specimens
were identiﬁed that exhibited criteria of advanced rupture-prone atheroscle-
rotic plaques, and histological and immunohistological analysis of markers of
apoptosis (cleaved Caspase-3, TUNEL) and UPR (KDEL, ATF3, CHOP,
CHAC-1) was performed. In addition, co-localization of apoptosis and
UPR-activation was assessed by double-immunohistochemistry.
Results: The mean size of the necrotic core was 44 6 7% and the
mean minimum/representative thicknesses of the ﬁbrous cap were 129 6
39 mm/280 6 60 mm, respectively. Each specimen fulﬁlled at least two
of the criteria for rupture-prone plaques. Semi-quantitative analysis of
immunohistochemistry showed a signiﬁcant increase in cleaved Caspase-3-
positive (1923 6 93 cells/mm2) and TUNEL-positive cells (1387 6 66
cells/mm2) when compared with control tissue. Furthermore, expression
of UPR-markers KDEL, AFT3 and CHOP was signiﬁcantly increased
(1175 6 40 cells/mm2, 1971 6 69 cells/mm2 and 2173 6 120 cells/
mm2, respectively). Co-localization of UPR-activation with apoptosis was
conﬁrmed by double-immunohistochemistry, and lesional macrophages
were identiﬁed as the primary cell-type involved.
Conclusion: For the ﬁrst time, activation of the proapoptotic
signaling pathway UPR has been identiﬁed in advanced rupture-prone pla-
ques of the human carotid artery. This provides additional evidence for add-
ing UPR to the potential targets for controlling plaque apoptosis and
thereby preventing plaque progression/rupture.
Temporary Aneurysm Sac Perfusion as an Adjunct for Prevention of
Spinal Cord Ischemia After Branched Endovascular Repair of
Thoracoabdominal Aneurysms
Kasprzak P.M., Gallis K., Cucuruz B., Pﬁster K., Janotta M., Kopp R. Eur J
Vasc Endovasc Surg 2014;48:260-7.
Objective: To report experience with the concept of temporary aneu-
rysm sac perfusion (TASP) and second stage side branch completion to pre-
vent severe spinal cord ischemia (SCI) after branched endovascular aortic
repair (bEVAR) for thoracoabdominal aortic aneurysm (TAAA).
Methods: Patients were treated for TAAA with bEVAR between
January 2009 and September 2012. TASP was performed by non-comple-
tion of side branches to one of the reno-visceral arteries, distal aortic or iliac
extensions with secondary side branch completion. Primary endpoints of the
study were overall technical success, side branch patency, perioperative mor-
tality, and the rate of severe SCI.
Results: Eighty-three patients were treated for TAAA with branched
aortic stent grafts with (n = 40) or without (n = 43) TASP. Overall technical
success, including aneurysm exclusion, absence of persistent type I or III
endoleak, TASP side branch patency, and secondary side branch completion
was 35/40 (88%). Secondary TASP side branch completion was performed
after a median of 48 days (range 1 e370 days). The rate of early re-interven-
tions for reno-visceral side branch complications was 8/283 (3%) and 6/83
(7%) for perioperative mortality, with three patients in both groups. Severe
SCI or paraplegia was observed in 11/83 (13%) of the patients and reduced
in the TASP group (2/40) compared with the non-TASP group (9/43; p =
.03), especially in Crawford I eIII aneurysms (1/29 vs. 7/24; p = .01).
However, one TASP patient died 4 months after bEVAR during the
TASP interval from suspected aorto-bronchial ﬁstula.
Conclusion: The concept of TASP after bEVAR for TAAA is feasible
and seems to reduce the risk of SCI. Early side TASP branch completion
within 4 weeks is recommended to reduce the risk of rupture, although,according to the individual clinical presentation, a longer TASP interval
might improve neurological rehabilitation from SCI.
Endovascular Repair of Acute Uncomplicated Aortic Type B
Dissection Promotes Aortic Remodelling: 1 Year Results of the
ADSORB Trial
Brunkwall J., Kasprzak P., Verhoeven E., Heijmen R., Taylor P., the
ADSORB Trialists, Alric P., Canaud L., Janotta M., Raithel D.,
Malina M., Resch Ti., Eckstein H.-H., Ockert S., Larzon T., Carlsson F.,
Schumacher H., Classen S., Schaub P., Lammer J., Lönn L.,
Clough R.E., Rampoldi V., Trimarchi S., Fabiani J.-N., Böckler D.,
Kotelis D., Böckler D., Kotelis D., von Tenng-Kobligk H.,
Mangialardi N., Ronchey S., Dialetto G., Matoussevitch V. Eur J Vasc
Endovasc Surg 2014;48:287-93.
Objectives: Uncomplicated acute type B aortic dissection (AD)
treated conservatively has a 10% 30-day mortality and up to 25% need inter-
vention within 4 years. In complicated AD, stent grafts have been encour-
aging. The aim of the present prospective randomised trial was to
compare best medical treatment (BMT) with BMT and Gore TAG stent
graft in patients with uncomplicated AD. The primary endpoint was a com-
bination of incomplete/no false lumen thrombosis, aortic dilatation, or
aortic rupture at 1 year.
Methods: The AD history had to be less than 14 days, and exclusion
criteria were rupture, impending rupture, malperfusion. Of the 61 patients
randomised, 80% were DeBakey type IIIB.
Results: Thirty-one patients were randomised to the BMT group and
30 to the BMT+TAG group. Mean age was 63 years for both groups. The
left subclavian artery was completely covered in 47% and in part in 17% of
the cases. During the ﬁrst 30 days, no deaths occurred in either group,
but there were three crossovers from the BMT to the BMT+TAG group,
all due to progression of disease within 1 week. There were two withdrawals
from the BMT+TAG group. At the 1-year follow up there had been another
two failures in the BMT group: one malperfusion and one aneurysm forma-
tion (p = .056 for all). One death occurred in the BMT+TAG group. For
the overall endpoint BMT+TAG was signiﬁcantly different from BMT
only (p < .001). Incomplete false lumen thrombosis, was found in 13
(43%) of the TAG+BMT group and 30 (97%) of the BMT group (p <
.001). The false lumen reduced in size in the BMT+TAG group (p <
.001) whereas in the BMT group it increased. The true lumen increased
in the BMT+TAG (p < .001) whereas in the BMT group it remained un-
changed. The overall transverse diameter was the same at the beginning
and after 1 year in the BMT group (42.1 mm), but in the BMT+TAG it
decreased (38.8 mm; p = .062).
Conclusions: Uncomplicated AD can be safely treated with the Gore
TAG device. Remodelling with thrombosis of the false lumen and reduction
of its diameter is induced by the stent graft, but long term results are
needed.
In Situ Reconstruction in Native and Prosthetic Aortic Infections
Using Cryopreserved Arterial Allografts
Touma J., Cochennec F., Parisot J., Fialaire Legendre A., Becquemin J.-P.,
Desgranges P. Eur J Vasc Endovasc Surg 2014;48:294-301.
Objectives: To evaluate overall survival and complications of cryopre-
served arterial allografts in aortic graft infections and infected aortic
aneurysms.
Results: During the study period, 54 patients (45 [83%] men, mean
age 66.26 10.2 years) underwent aortic reconstruction using cryopreserved
allografts. Indications were native aortic infection in 17 patients and pros-
thetic graft infection in 37 patients, including seven aortoenteric ﬁstulae.
Twelve aortic reconstructions (22%) were performed as emergency proce-
dures. The median duration of follow-up was 12.1 months (range
0.4e83.6). The 30-day mortality rate was 28%. The overall mortality rate807
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ative complications occurred in 52% of patients. The graft-related mortality
rate was 7%. The graft-related complication rate was 19%. During follow-up,
there were two recurrences of aortic infection and two recurrences of allo-
graft limb occlusion. Multivariate survival analysis identiﬁed age, chronic
renal disease, prosthetic infection, emergent procedure, and coronary dis-
ease as independent predictors for postoperative mortality.
Conclusion: This experience with cryopreserved aortic allografts in
aortic reconstructions shows an unsatisfactory 30-day survival rate, as well
as a substantial early graft-related complication rate. Longer follow-up is
needed in order to support the preferential use of cryopreserved allografts
based on their long-term behavior.
Prognostic Impact of Arterial Stiffness in Patients with Symptomatic
Peripheral Arterial Disease
Kals J., Lieberg J., Kampus P., Zagura M., Eha J., Zilmer M. Eur J Vasc
Endovasc Surg 2014;48:310-7.
Objectives: Arterial stiffness (AS) is increasingly recognized as an in-
dependent risk factor in different high-risk populations. Whether changes
in AS can predict prognosis in patients with symptomatic peripheral arterial
disease (PAD) has never been investigated. The aim of the present study was
to test the hypothesis that AS is an independent predictor of all-cause and
cardiovascular disease (CVD) mortality in patients with symptomatic PAD.
Methods: A cohort of 117 symptomatic PAD patients (aged 62.3 6
7.7 years) were prospectively recruited from the Department of Vascular
Surgery, Tartu University Hospital, between 2002 and 2010. The AS was
measured using pulse wave analysis and assessment of pulse wave velocity
(PWV).
Results: During the follow-up period (mean 4.1 6 2.2 years) there
were 32 fatal events. KaplaneMeier analysis showed that the probability
of all-cause and CVD mortality decreased with increasing small artery elas-
ticity (SAE), as estimated by the log-rank test (p = .004; p = .005, respec-
tively). By contrast, large artery elasticity, augmentation index, and aortic
and brachial PWV were not signiﬁcantly related to mortality. In a Cox pro-
portional hazard model, SAE above the median was associated with
decreased all-cause and CVD mortality after adjustment for confounding
factors: relative risk (RR), 0.37; 95% conﬁdence interval (CI), 0.17e0.81;
p = .01; RR, 0.11; 95% CI, 0.01e0.86; p = .04, respectively).
Conclusions: This study provides the ﬁrst evidence, obtained from an
observational study, that decreased small artery elasticity is an independent
predictor of all-cause and CVD mortality in patients with symptomatic
PAD.
Efﬁcacy of Revascularization for Critical Limb Ischemia in Patients
with End-stage Renal Disease
Yamamoto S., Hosaka A., Okamoto H., Shigematsu K., Miyata T.,
Watanabe T. Eur J Vasc Endovasc Surg 2014;48:318-26.
Objective: To evaluate the outcomes of surgical revascularization for
critical limb ischemia in patients with end-stage renal disease (ESRD).Patients and methods: From 2004 to 2010, 184 patients with 213
critically ischaemic limbs caused by arteriosclerosis were admitted to The
University of Tokyo Hospital. The outcomes of primarily surgical revascu-
larization-based treatments were retrospectively compared in patients with
ESRD (ESRD group: 79 patients, 101 limbs) and without ESRD (non-
ESRD group: 105 patients, 112 limbs) during the same period.
Results: Arterial reconstruction was performed on 56 limbs in 46 pa-
tients in the ESRD group and 78 limbs in 73 patients in the non-ESRD
group (55% vs. 70%; p = .03). Major amputation was performed in 6 of
48 limbs with patent grafts in the ESRD group because of uncontrolled
infection or progression of necrosis. The limb salvage rate after arterial
reconstruction was signiﬁcantly lower in the ESRD group than in the
non-ESRD group (p = .0019). The postoperative survival rate was lower
in the ESRD group than in the non-ESRD group, although this difference
was not signiﬁcant (p = .052). Associated cardiovascular disease and systemic
infection were the most frequent causes of death in the ESRD group. There
was no signiﬁcant difference in graft patency between the two groups after
distal bypass surgery; however, the limb salvage rate was signiﬁcantly lower
in the ESRD group than in the non-ESRD group (p = .03).
Conclusions: Critical limb ischemia associated with ESRD has a poor
prognosis. Infection control is particularly important for achievement of
good treatment outcomes.
The Effect of Deep Venous Stenting on Healing of Lower Limb
Venous Ulcers
George R., Verma H., Ram B., Tripathi R. Eur J Vasc Endovasc Surg
2014;48:332-8.
Objective: To report the outcomes of endovascular interventions on
deep veins in patients with venous ulcers (C6).
Methods: This was a retrospective review of a case series. All patients
with active venous ulceration who underwent endovascular interventions to
the deep venous system from February 2011 to June 2013 were included.
Patients with C6 disease who failed a trial of adequate compression therapy
or superﬁcial vein interventions were considered for evaluation of the deep
veins. Patients with deep vein reﬂux or without signiﬁcant venous reﬂux or
with a previous history of deep vein thrombosis underwent computed tomo-
graphic venogram or ascending venogram. In the absence of intravenous ul-
trasound trial ballooning to look for a “waist” to identify subtle lesions was
used. Lesions were stented with long Nitinol stents.
Results: Thirty-eight patients underwent deep vein stenting of 44
limbs with venous ulcers. The lesions were considered to be post-throm-
botic in 31 limbs and non-thrombotic iliac vein lesions in 13 limbs. A
mean of 1.8 stents were used per patient. There were no signiﬁcant compli-
cations associated with the interventions. At a median follow-up of 15
months, the primary and assisted primary patency rates were 94% and
97%, respectively. Sustained ulcer healing was achieved in 60% of limbs. A
further 20% of ulcers had reduced in size. Recurrent ulcers developed in
13% of limbs, and half of these healed with interventions for newly devel-
oped incompetence in superﬁcial veins.
Conclusion: Endovascular interventions to the deep veins appear to
be an effective adjunct in achieving the healing of recalcitrant ulcers.
